The cancer Alzheimer's disease paradox
A new study explores the inverse epidemiological relationship between cancer and Alzheimer's disease, suggesting that biological mechanisms protecting against one condition may increase susceptibility to the other, potentially opening new avenues for therapeutic research.
Background
- The "cancer–Alzheimer's disease paradox" refers to a well-documented epidemiological finding: people who develop cancer are statistically less likely to get Alzheimer's disease, and vice versa. This inverse relationship has puzzled researchers for years.
- This paper explores possible biological mechanisms behind the paradox — e.g., shared genetic pathways, cellular stress responses (like the unfolded protein response), or trade-offs between cell proliferation (cancer) and cell death (neurodegeneration).
- Understanding why these two diseases seem to oppose each other could lead to new therapeutic strategies for both conditions. If the same biological switch protects against one while raising risk for the other, targeting it carefully might treat either disease.
- The study is published in *Nature*'s partner journal *npj Aging*, a peer-reviewed venue for research on the biology of aging.